Monoamine precursors in the treatment of depression.
D006916:5-Hydroxytryptophan / Q000378:metabolism; D000480:Alkynes / Q000627:therapeutic use; D000596:Amino Acids / Q000378:metabolism; D001921:Brain / Q000378:metabolism; D002396:Catechols / Q000652:urine; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy*; D003864:Depression, Chemical; D004295:Dihydroxyphenylalanine / Q000494:pharmacology / Q000627:therapeutic use*; D004357:Drug Synergism; D004565:Electroconvulsive Therapy; D006018:Glycols / Q000652:urine; D006801:Humans; D007737:Kynurenine / Q000378:metabolism; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D009638:Norepinephrine / Q000096:biosynthesis; D010300:Parkinson Disease / Q000188:drug therapy; D010636:Phenols / Q000627:therapeutic use; D011437:Propylamines / Q000627:therapeutic use; D011736:Pyridoxine / Q000627:therapeutic use; D012694:Serine / Q000378:metabolism; D012701:Serotonin / Q000378:metabolism; D013237:Stereoisomerism; D014364:Tryptophan / Q000378:metabolism / Q000627:therapeutic use* / Q000633:toxicity; D014443:Tyrosine / Q000378:metabolism; D014642:Vanilmandelic Acid / Q000652:urine
D000480:Alkynes; D000596:Amino Acids; D002396:Catechols; D006018:Glycols; D008996:Monoamine Oxidase Inhibitors; D010636:Phenols; D011437:Propylamines; D012701:Serotonin; D007737:Kynurenine; D014443:Tyrosine; D012694:Serine; D014642:Vanilmandelic Acid; D004295:Dihydroxyphenylalanine; D014364:Tryptophan; D006916:5-Hydroxytryptophan; D011736:Pyridoxine; D009638:Norepinephrine